Trial ID or NCT#

NCT01938495

Status

RECRUITING

Purpose

The study is being conducted to determine if DPS treatment for people with ALS and hypoventilation is associated with improved survival or diaphragm function. The primary objective of the study is to conduct a multi-center, randomized controlled clinical trial comparing standard of care (control) to diaphragm stimulator treatment with the NeuRx® Diaphragm Pacing System™ (DPS) with respect to survival. The secondary objective of the study is to conduct a multi-center, randomized controlled clinical trial to compare standard of care treatment (control) to DPS in ALS subjects with hypoventilation.

Official Title

Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)

Eligibility Criteria

Ages Eligible for Study: Older than 21 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Yuen So, MD, PhD
Neuromuscular neurologist, Neurophysiologist
Professor of Neurology at the Stanford University Medical Center
Sarada Sakamuri, MD
Neuromuscular neurologist, General neurologist, Neurophysiologist
Clinical Assistant Professor, Neurology & Neurological Sciences

Contact us to find out if this trial is right for you.

CONTACT

Shirley Paulose
(650) 724-3792